13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q2 2019. See the latest, Q2 2026 →
Reported value
$451.69B
+2.3% on the quarter before
Positions
2,039
187 new · 171 sold out
Top 10
14.7%
of the value
Est. gain
+$13.98B
on stocks held all quarter
Est. return
+3.4%
on those stocks since Q1 2019
Positions as of Jun 30, 2019, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 28% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.
Largest buys
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pfizer Inc~$2.57BAdded · 0.7% → 1.3%+59,425,743 shares
- Tc Energy Corp~$1.51BNew · 0.0% → 0.3%+30,329,885 shares
- Alcon Inc~$847.5MNew · 0.0% → 0.2%+13,706,926 shares
- Bank Amer Corp~$665.9MAdded · 1.3% → 1.5%+22,961,000 shares
- Raytheon Co~$600.0MAdded · 0.2% → 0.3%+3,450,691 shares
- Dupont De Nemours Inc~$567.3MNew · 0.0% → 0.1%+7,556,442 shares
- Coca Cola Co~$560.1MAdded · 0.9% → 1.0%+11,000,079 shares
- Unitedhealth Group Inc~$552.5MAdded · 1.6% → 1.7%+2,264,182 shares
- Boston Properties Inc~$544.0MAdded · 0.0% → 0.1%+4,217,358 shares
- Dow Inc~$537.4MNew · 0.0% → 0.1%+10,898,871 shares
Largest sells
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dowdupont Inc~$2.15BSold out · 0.5% → 0.0%−40,312,480 shares
- Transcanada Corp~$1.42BSold out · 0.3% → 0.0%−31,515,001 shares
- Wells Fargo Co New~$1.03BCut · 0.3% → 0.0%−21,702,420 shares
- Qualcomm~$893.6MCut · 0.2% → 0.0%−11,747,691 shares
- American Tower~$699.8MCut · 1.2% → 1.1%−3,423,009 shares
- Alibaba~$639.1MCut · 0.7% → 0.5%−3,771,710 shares
- Merck & Co Inc~$635.0MCut · 1.2% → 1.0%−7,573,495 shares
- Citigroup Inc~$604.7MCut · 0.2% → 0.1%−8,634,799 shares
- Bristol Myers Squibb Co~$541.9MCut · 1.4% → 1.1%−11,950,250 shares
- Eli Lilly~$540.1MCut · 1.1% → 0.8%−4,874,886 shares
Holdings
As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −3.3% · price +13.6% | 2.3% | $10.27B | +$1.23B | ||||||||
| Unitedhealth Group IncCOM · shares +7.9% · price −1.3% | 1.7% | $7.55B | −$93.2M | ||||||||
| Medtronic PlcSHS · shares +3.2% · price +6.9% | 1.5% | $6.87B | +$431.3M | ||||||||
| Verizon Communications IncCOM · shares −0.5% · price −3.4% | 1.5% | $6.84B | −$239.5M | ||||||||
| Bank Amer CorpCOM · shares +11% · price +5.1% | 1.5% | $6.82B | +$299.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.2% · price +10.4% | 1.4% | $6.42B | +$593.7M | ||||||||
| Pfizer IncCOM · shares +79% · price +2.0% | 1.3% | $5.84B | +$64.0M | ||||||||
| AmazonCOM · shares +6.3% · price +6.3% | 1.2% | $5.29B | +$296.8M | ||||||||
| Comcast Corp NewCL A · shares +0.3% · price +5.8% | 1.2% | $5.22B | +$282.9M | ||||||||
| Bristol Myers Squibb CoCOM · shares −9.5% · price −4.9% | 1.1% | $5.15B | −$268.1M | ||||||||
| Chevron Corp NewCOM · shares +0.3% · price +1.0% | 1.1% | $5.07B | +$51.2M | ||||||||
| American TowerCOM · shares −12% · price +3.8% | 1.1% | $4.91B | +$177.7M | ||||||||
| Coca Cola CoCOM · shares +13% · price +8.7% | 1.0% | $4.71B | +$330.9M | ||||||||
| Merck & Co IncCOM · shares −12% · price +0.8% | 1.0% | $4.62B | +$37.5M | ||||||||
| Lockheed Martin CorpCOM · shares −1.5% · price +21.1% | 1.0% | $4.59B | +$800.0M | ||||||||
| Chubb LimitedCOM · shares −0.9% · price +5.1% | 0.97% | $4.39B | +$214.9M | ||||||||
| AlphabetCAP STK CL A · shares +1.9% · price −8.0% | 0.94% | $4.27B | −$364.1M | ||||||||
| Home Depot IncCOM · shares +14% · price +8.4% | 0.90% | $4.09B | +$277.8M | ||||||||
| Exxon Mobil CorpCOM · shares +1.5% · price −5.2% | 0.90% | $4.06B | −$217.7M | ||||||||
| Allergan PlcSHS · shares −7.5% · price +14.4% | 0.84% | $3.82B | +$479.1M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −2.7% · price +11.9% | 0.83% | $3.73B | +$397.5M | ||||||||
| Abbott LabsCOM · shares −4.2% · price +5.2% | 0.82% | $3.72B | +$184.1M | ||||||||
| Pepsico IncCOM · shares −6.0% · price +7.0% | 0.82% | $3.69B | +$241.3M | ||||||||
| CiscoCOM · shares −2.9% · price +1.4% | 0.81% | $3.68B | +$49.7M | ||||||||
| Eli LillyCOM · shares −13% · price −14.6% | 0.78% | $3.52B | −$603.5M | ||||||||
| Total · 2,039 positions | 100% | $451.69B | +$13.98B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2019 to Q2 2019: 1,792 stocks held throughout, up $13.98B (+3.4%).
- Microsoft+$1.23B+14%
- Lockheed Martin Corp+$800.0M+21%
- Jpmorgan Chase & Co+$593.7M+10%
- Allergan Plc+$479.1M+14%
- Medtronic Plc+$431.3M+7%
- Alphabet−$364.1M−8%
- Teva Pharmaceutical Inds Ltd−$377.3M−41%
- Intel−$427.6M−11%
- Mylan N V−$452.7M−33%
- Eli Lilly−$603.5M−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |